Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2018 April;66(2) > Minerva Cardioangiologica 2018 April;66(2):198-204

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW  DIFFERENT APPROACHES TO AORTIC VALVE TREATMENT: SUTURELESS AVR VERSUS TAVI 

Minerva Cardioangiologica 2018 April;66(2):198-204

DOI: 10.23736/S0026-4725.17.04552-2

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

The role of SU-AVR in tomorrow’s practice of AVR

Dani BITRAN , Shuli SILBERMAN

Department of Cardiothoracic Surgery, Shaare Zedek Medical Center, Jerusalem, Israel


PDF


Conventional aortic valve replacement (C-AVR) is the golden standard in the treatment of severe aortic stenosis (AS). Despite its tremendous success there are many problems associated with the procedure. A large segment of the AS population is not suitable for surgery because of the excessive risk. Over the few last years, transcatheter aortic valve implantation and the use of sutureless valves are new technologies that aim to replace the C-AVR. In this review we compare the three therapeutic modalities in treating severe AS. Based on accumulated data we aspire to describe the clinical landscape of AVR in the near future. We will try to delineate how sutureless valves will be used in treating severe AS.


KEY WORDS: Aortic Stenosis - Aortic Valve Replacement - Transcatheter Aortic Valve Implantation - Sutureless valves - Conventional Aortic Valve Replacement

top of page